Patent ID: 11964973
Assignee: BRISTOL-MYERS SQUIBB COMPANY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 2:
3. The compound according to claim 1 or a salt thereof, wherein:
L is —O—, —NH—, —N(CH3)—, or —N(CH3)C(O)—;
R1 is F, Cl, Br, —CN, —OCH3, or —C(O)NH2;
R2 is —CH3;
R3 is H, F, Cl, Br, —CN, —CH3, —NO2, methylpyridinyl, or methoxypyridinyl;
R4 is R4a or —CH2R4a;
R4a is cyclohexyl, phenyl, indazolyl, phthalazinyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzothiazolyl, quinolinyl, quinoxalinyl, quinazolinyl, 1,7-naphthyridinyl, or dihydrobenzo[b][1,4]dioxepinyl, each substituted with zero to 3 R4b;
each R4b is independently F, Cl, Br, —CN, —CH3, —CH2CH3, —CH2CH2CH3, —CH(CH3)2, —CH2CH2CH2CH3, —C(CH3)3, —CH2CH2CH2CH2CH3, —C(CH3)2CH2CH3, —CHF2, —CF3, —OCH3, —OCH(CH3)2, —OC(CH3)3, —OCF3, —C(O)N(CH3)2, —S(O)2CH3, —CH2(phenyl), —C(CH3)2(phenyl), cyclopropyl, cyclopentyl, or cyclohexyl;
each R5 is independently hydrogen, F, —OH, C1-2 alkyl, C1-3 alkoxy, —CH2CF3, —OCH2CH2OCH3, —OCH2CH2N(CH3)2, —OCH2(cyclopropyl), or —OCH2CH2(morpholinyl); and
each R6 is H.